Clinical Trials
6 trialsNCT06297369 2024-03-07
Evaluation of the Effect of N-acetylcysteine in Preventing Cisplatin-Induced Toxicities in Cancer Patients
Ain Shams University
Phase 2 Unknown
NCT06039280 2023-09-15
Comparison of Dexamethasone and N Acetylcysteine (NAC) Versus N Acetylcysteine (NAC) Alone in the Prevention of Post Embolization Syndrome in Patients With Hepatocellular Carcinoma Following Transarterial Chemoembolization.
Institute of Liver and Biliary Sciences, India
Phase NA Unknown
NCT04291209 2023-09-06
Intratympanic N-Acetylcysteine for Prevention of Cisplatin-induced Ototoxicity.
Sunnybrook Health Sciences Centre
Phase 1/2 Unknown
NCT04982146 2022-06-02
Intratumoral Bromelain + Acetylcysteine in Relapsed and Unresectable Pseudomyxoma Peritonei
Maimónides Biomedical Research Institute of Córdoba
Phase 1 Unknown
NCT03976973 2022-03-15
BromAc for Recurrent Peritoneal Mucinous Tumour or Pseudomyxoma Peritonei
Mucpharm Pty Ltd
Phase 2 Unknown
NCT02241876 2014-09-16
THE USE OF N-ACETYLCYSTEINE ATTENUATING CISPLATIN-INDUCED TOXICITIES BY OXIDATIVE STRESS
University of Campinas, Brazil
Phase 4 Unknown